Location: New York, NY
CIK: 0001826434 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $770M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | 603,143 | $125M | 16.2% | $183.20 | +7.5% | COM | 478160104 |
| DHR | DANAHER CORPORATION | 346,875 | $79.41M | 10.3% | $219.54 | 0.0% | COM | 235851102 |
| LLY | ELI LILLY & CO | 63,284 | $68.01M | 8.8% | $955.55 | 0.0% | COM | 532457108 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 120,921 | $58.92M | 7.7% | $336.31 | +38.5% | COM | 91307C102 |
| ASND | ASCENDIS PHARMA A/S | 265,015 | $56.51M | 7.3% | $187.08 | — | SPONSORED ADR | 04351P101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 86,023 | $50.09M | 6.5% | $319.67 | +59.8% | COM | 558868105 |
| BSX | BOSTON SCIENTIFIC CORP | 520,508 | $49.63M | 6.4% | $98.04 | 0.0% | COM | 101137107 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,435,865 | $44.81M | 5.8% | $31.21 | — | SPONSORED ADS | 881624209 |
| IONS | IONIS PHARMACEUTICALS INC | 557,174 | $44.08M | 5.7% | $75.30 | 0.0% | COM | 462222100 |
| VERA | VERA THERAPEUTICS INC | 805,689 | $40.8M | 5.3% | $24.12 | +47.2% | CL A | 92337R101 |
| AXSM | AXSOME THERAPEUTICS INC | 201,627 | $36.83M | 4.8% | $101.43 | +37.6% | COM | 05464T104 |
| ARGX | ARGENX SE | 37,653 | $31.66M | 4.1% | $507.27 | — | SPONSORED ADR | 04016X101 |
| NUVL | NUVALENT INC | 307,371 | $30.92M | 4.0% | $98.60 | 0.0% | COM | 670703107 |
| DXCM | DEXCOM INC | 421,600 | $27.98M | 3.6% | $64.65 | 0.0% | COM | 252131107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 622,403 | $25.65M | 3.3% | $34.89 | +11.1% | COM | 252828108 |